Smithbridge Asset Management Inc Laboratory Corp Of America Holdings Transaction History

Smithbridge Asset Management Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$209.01 - $232.56 $1,254 - $1,395	-6 Reduced 0.05%	11,573 $2.53 Million
Q4 2023 Jan 18, 2024	BUY	$197.69 - $227.29 $77,296 - $88,870	391 Added 3.49%	11,579 $2.63 Million
Q3 2023 Oct 25, 2023	BUY	$201.05 - $221.7 $51,669 - $56,976	257 Added 2.35%	11,188 $2.25 Million
Q2 2023 Jul 20, 2023	BUY	$211.93 - $241.33 $240,752 - $274,150	1,136 Added 11.6%	10,931 $2.64 Million
Q2 2023 Jul 18, 2023	SELL	$211.93 - $241.33 $183,955 - $209,474	-868 Reduced 8.14%	9,795 $2.31 Million
Q1 2023 Apr 20, 2023	BUY	$213.32 - $257.83 $185,161 - $223,796	868 Added 8.86%	10,663 $2.45 Million
Q4 2022 Mar 01, 2023	SELL	$203.72 - $248.97 $161,753 - $197,682	-794 Reduced 7.5%	9,795 $2.31 Million
Q3 2022 Oct 25, 2022	BUY	$204.81 - $262.19 $539,469 - $690,608	2,634 Added 33.11%	10,589 $2.17 Million
Q2 2022 Aug 03, 2022	BUY	$213.86 - $277.87 $213,860 - $277,870	1,000 Added 14.38%	7,955 $1.86 Million
Q1 2022 Apr 25, 2022	BUY	$259.82 - $298.18 $1.81 Million - $2.07 Million	6,955 New	6,955 $1.83 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Smithbridge Asset Management Inc with notifications on news.